Substance Misuse in Patients with Schizophrenia

[1]  K. Mueser,et al.  Disulfiram treatment for alcoholism in severe mental illness. , 2003, The American journal on addictions.

[2]  A. Tanskanen,et al.  Incidence of cancer among persons with schizophrenia and their relatives. , 2001, Archives of general psychiatry.

[3]  V. Sunderland,et al.  Getting to grips with heroin and other opioid use , 2001, The Medical journal of Australia.

[4]  R. Buchanan,et al.  Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia. , 2001, The American journal of psychiatry.

[5]  Michelle P. Salyers,et al.  Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia , 2001, Schizophrenia Research.

[6]  G. Currier.  Atypical antipsychotic medications in the psychiatric emergency service. , 2000, The Journal of clinical psychiatry.

[7]  L. Degenhardt,et al.  How many dependent heroin users are there in Australia? , 2000, The Medical journal of Australia.

[8]  D. Ziedonis,et al.  Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. , 2000, The American journal of psychiatry.

[9]  C. Steele.  Zyban: an effective treatment for nicotine addiction. , 2000, Hospital medicine.

[10]  E. Rüther,et al.  Myocarditis Associated with Clozapine Treatment , 2000 .

[11]  K. Carey,et al.  Utility of collateral information in assessing substance use among psychiatric outpatients. , 2000, Journal of substance abuse.

[12]  P. Jacob,et al.  Clinical pharmacology of oral cotinine. , 2000, Drug and alcohol dependence.

[13]  R. Emsley.  Role of Newer Atypical Antipsychotics in the Management of Treatment-Resistant Schizophrenia , 2000 .

[14]  D. Kavanagh,et al.  Towards an integrated and family-sensitive intervention for comorbid substance abuse and schizophrenia : a comment on Sheils and Rolfe , 2000 .

[15]  A. Bellack,et al.  Sex differences in illness presentation, course, and level of functioning in substance-abusing schizophrenia patients , 2000, Schizophrenia Research.

[16]  D Castle,et al.  Psychotic Disorders in Urban Areas: An Overview of the Study on Low Prevalence Disorders , 2000, The Australian and New Zealand journal of psychiatry.

[17]  J. Maxwell.  Changes in drug use in Australia and the United States: results from the 1995 and 1998 National Household Surveys , 2000 .

[18]  R. Weiss,et al.  Schizophrenia, substance use disorders and medical co-morbidity. , 2000, The journal of mental health policy and economics.

[19]  A. Green,et al.  Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. , 2000, Journal of clinical psychopharmacology.

[20]  J. Warnock,et al.  Treatment Augmentation With Opiates in Severe and Refractory Major Depression , 1999, American Journal of Psychiatry.

[21]  J. Mcgrath,et al.  Treatment of schizophrenia , 1999 .

[22]  M. Pantalon,et al.  Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. , 1999, The Journal of nervous and mental disease.

[23]  K. Mueser,et al.  Social networks and clinical outcomes of dually diagnosed homeless persons , 1999 .

[24]  O. Pomerleau,et al.  Nicotine Withdrawal and Psychiatric Symptoms in Cigarette Smokers with Schizophrenia , 1999, Neuropsychopharmacology.

[25]  J. McEvoy,et al.  Smoking and therapeutic response to clozapine in patients with schizophrenia , 1999, Biological Psychiatry.

[26]  C. Adams,et al.  Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. , 1999, The American journal of psychiatry.

[27]  A. Evins,et al.  Bupropion and smoking cessation. , 1999, The American journal of psychiatry.

[28]  Trevor R. Norman.  Book Review: Psychotropic Drug Handbook, 7th ed. , 1999 .

[29]  J. Krystal,et al.  Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients , 1999, Schizophrenia Research.

[30]  D. Casey.  Tardive dyskinesia and atypical antipsychotic drugs , 1999, Schizophrenia Research.

[31]  S. Leucht,et al.  Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials , 1999, Schizophrenia Research.

[32]  J. Addington,et al.  Group treatment for smoking cessation among persons with schizophrenia. , 1998, Psychiatric services.

[33]  H. Graham.  THE ROLE OF DYSFUNCTIONAL BELIEFS IN INDIVIDUALS WHO EXPERIENCE PSYCHOSIS AND USE SUBSTANCES: IMPLICATIONS FOR COGNITIVE THERAPY AND MEDICATION ADHERENCE , 1998, Behavioural and Cognitive Psychotherapy.

[34]  S. Woods,et al.  Naltrexone augmentation of neuroleptics in schizophrenia. , 1998, Journal of clinical psychopharmacology.

[35]  R. Drake,et al.  Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial. , 1998, The American journal of orthopsychiatry.

[36]  V. Backus.  Treatment Strategies for Patients With Psychiatric Comorbidity , 1998 .

[37]  D. Kavanagh,et al.  Substance Treatment Options in Psychosis (STOP) : a new intervention for dual diagnosis , 1998 .

[38]  R. Drake,et al.  Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness. , 1998, The American journal of psychiatry.

[39]  J. Tiihonen,et al.  731 Schizophrenia, alcohol abuse and violent behaviour A 26-year follow-up study of an unselected birth cohort , 1997, Schizophrenia Research.

[40]  K. Carey,et al.  Reliability and validity of the Addiction Severity Index among outpatients with severe mental illness , 1997 .

[41]  D. Luchins,et al.  The impact of substance use screening on a public psychiatric inpatient population. , 1997, Psychiatric services.

[42]  J. Gray,et al.  Habituation and prepulse inhibition of the acoustic startle reflex: Effects of smoking status and psychosis-proneness , 1997 .

[43]  R. Heslegrave,et al.  Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse. , 1997, The Journal of nervous and mental disease.

[44]  S. Marder,et al.  Does risperidone improve verbal working memory in treatment-resistant schizophrenia? , 1997, The American journal of psychiatry.

[45]  T. Barnes,et al.  Detecting comorbid substance misuse among people with schizophrenia in the community: a study comparing the results of questionnaires with analysis of hair and urine , 1997, Schizophrenia Research.

[46]  J. Hughes,et al.  The efficacy of disulfiram: a review of outcome studies. , 1997, Addiction.

[47]  G. Tollefson,et al.  Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine. , 1997, American Journal of Psychiatry.

[48]  R. Drake,et al.  Gender differences in patients with schizophrenia and substance abuse. , 1997, Comprehensive psychiatry.

[49]  E. Levin,et al.  Nicotine–Haloperidol Interactions and Cognitive Performance in Schizophrenics , 1996, Neuropsychopharmacology.

[50]  H. Scurlock,et al.  Another case of nicotine psychosis? , 1996, Addiction.

[51]  R. Owen,et al.  Medication noncompliance and substance abuse among patients with schizophrenia. , 1996, Psychiatric services.

[52]  E. Levin,et al.  Nicotine-haloperidol interactions and cognitive performance in schizophrenia , 1996, Schizophrenia Research.

[53]  P. Marcus,et al.  Reduction of comorbid substance abuse with clozapine. , 1995, The American journal of psychiatry.

[54]  Herman Aguinis,et al.  Enhancing the validity of self-reported alcohol and marijuana consumption using a bogus pipeline procedure: A meta-analytic review. , 1995 .

[55]  D. Kavanagh.  An Intervention for Substance Abuse in Schizophrenia , 1995, Behaviour Change.

[56]  J. Krystal,et al.  Short-term use of disulfiram with clozapine. , 1994, Journal of clinical psychopharmacology.

[57]  R. Rosenthal,et al.  Methadone withdrawal psychosis , 1994, Biological Psychiatry.

[58]  D. Ziedonis,et al.  Nicotine dependence and schizophrenia. , 1994, Hospital & community psychiatry.

[59]  C. Mercier,et al.  A Thirty-Year Retrospective Study of Hospitalization among Severely Mentally III Patients * , 1994, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[60]  N. Rector,et al.  Current cannabis use and tardive dyskinesia , 1993, Schizophrenia Research.

[61]  A. Wiser,et al.  Normalization of auditory physiology by cigarette smoking in schizophrenic patients. , 1993, The American journal of psychiatry.

[62]  L. Friedman,et al.  Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine , 1993, Biological Psychiatry.

[63]  R. Drake,et al.  Moderate drinking among people with severe mental illness. , 1993, Hospital & community psychiatry.

[64]  J. Lohr,et al.  Smoking and schizophrenia , 1992, Schizophrenia Research.

[65]  S. Loft,et al.  Disulfiram therapy –adverse drug reactions and interactions , 1992, Acta psychiatrica Scandinavica. Supplementum.

[66]  D. Goff,et al.  Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. , 1992, The American journal of psychiatry.

[67]  P. Urdal,et al.  Discrimination of smoking status by thiocyanate and cotinine in serum, and carbon monoxide in expired air. , 1992, International journal of epidemiology.

[68]  J. Sweeney,et al.  Increased tardive dyskinesia in alcohol-abusing schizophrenic patients. , 1992, Comprehensive Psychiatry.

[69]  J. Sweeney,et al.  Drug abuse in schizophrenic patients: clinical correlates and reasons for use. , 1991, The American journal of psychiatry.

[70]  D S Rae,et al.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. , 1990, JAMA.

[71]  R. Drake,et al.  Alcohol Use and Abuse in Schizophrenia: A Prospective Community Study , 1989, The Journal of nervous and mental disease.

[72]  P. Sugarman.  Psychotropic Drug Handbook , 1988 .

[73]  W. Potter,et al.  Psychoses associated with bupropion treatment. , 1985, The American journal of psychiatry.

[74]  M. Schuckit.  Drug and Alcohol Abuse , 1984, Critical Issues in Psychiatry.

[75]  G. McKenna.  METHADONE AND OPIATE DRUGS: PSYCHOTROPIC EFFECT AND SELF‐MEDICATION , 1982, Annals of the New York Academy of Sciences.

[76]  J. Volavka,et al.  Endorphins in psychiatry: an overview and a hypothesis. , 1978, Archives of general psychiatry.

[77]  N. Azrin,et al.  A community-reinforcement approach to alcoholism. , 1973, Behaviour research and therapy.

[78]  A. Hoffer,et al.  Why Schizophrenics Smoke but Have a Lower Incidence of Lung Cancer : Implications for the Treatment of Both Disorders , 2006 .

[79]  K. Lawler,et al.  A COMMUNITY-REINFORCEMENT APPROACH TO ALCOHOLISM* , 2002 .

[80]  R. Browne,et al.  Prevalence and patterns of substance misuse in schizophrenia: A catchment area case-control study , 2001 .

[81]  D. Kavanagh,et al.  Substance use in psychotic disorders: Results from the Australian survey of mental health and wellbeing , 2000 .

[82]  D. Feifel.  Rationale and guidelines for the inpatient treatment of acute psychosis. , 2000, The Journal of clinical psychiatry.

[83]  P. Yarnold,et al.  Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups. , 2000, Schizophrenia bulletin.

[84]  R. Drake,et al.  The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. , 2000, Schizophrenia bulletin.

[85]  E. Rüther,et al.  Myocarditis associated with clozapine treatment. , 2000, The Australian and New Zealand journal of psychiatry.

[86]  D. Kavanagh,et al.  An examination of the utility of the AUDIT in people with schizophrenia. , 2000, Journal of studies on alcohol.

[87]  R. Rosenheck,et al.  Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. , 1999, The American journal of psychiatry.

[88]  A. Patkar,et al.  Changing patterns of illicit substance use among schizophrenic patients: 1984-1996. , 1999, The American journal on addictions.

[89]  Cedric M. Smith,et al.  Obligatory cessation of smoking by psychiatric inpatients. , 1999, Psychiatric services.

[90]  A. Bellack,et al.  Treating substance abuse among patients with schizophrenia. , 1999, Psychiatric services.

[91]  W. Emmerson,et al.  Fortnightly review. Treatment of schizophrenia. , 1999, BMJ.

[92]  R. Drake,et al.  Review of integrated mental health and substance abuse treatment for patients with dual disorders. , 1998, Schizophrenia bulletin.

[93]  P. Cinciripini,et al.  The effects of smoking schedules on cessation outcome: can we improve on common methods of gradual and abrupt nicotine withdrawal? , 1995, Journal of consulting and clinical psychology.

[94]  Linda C. Sobell,et al.  Alcohol Timeline Followback 1979 , 1995 .

[95]  H. Meltzer,et al.  Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy. , 1994, The American journal of psychiatry.

[96]  T. Rummans,et al.  Disulfiram treatment of patients with both alcohol dependence and other psychiatric disorders: a review. , 1992, Alcoholism, clinical and experimental research.

[97]  W. Miller,et al.  Motivational Interviewing: Preparing People to Change Addictive Behavior , 1991 .

[98]  D. Levinson,et al.  Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. , 1990, Schizophrenia bulletin.

[99]  M. Schuckit,et al.  Drug and alcohol abuse : a clinical guide to diagnosis and treatment , 1979 .